Willingmed Secures Series B Funding to Advance Clinical Infection Diagnostics
Willingmed, a Beijing-based company specializing in molecular biology for clinical infection precision diagnosis, has reportedly...
Willingmed, a Beijing-based company specializing in molecular biology for clinical infection precision diagnosis, has reportedly...
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has struck a partnership with Shanghai...
Sino-US biopharma AnHeart Therapeutics and US precision oncology firm Guardant Health Inc. (NASDAQ: GH) have...
China-based gene testing service providers Tongshu Gene and LC Gene Diagnostics (Hangzhou) Co., Ltd. have...
Beijing Tsingke Biotech Co., Ltd. a gene synthesis company based in Beijing, reportedly raised RMB...
Salus Biomed, a sequencing and spatial omics platform provider based in Guangdong, has reportedly raised...
BGI Genomics Co., Ltd, a leading Chinese gene sequencing firm, has reportedly been added to...
China’s genomics giant BGI has revealed a landmark study using its proprietary Stereo-seq sequencing technology...
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has partnered with Genolmmune Therapeutics Biotechnology Co.,...
China-based gene testing platform company Mega Genomics Limited has successfully completed an initial public offering...